| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Division of Gynecologic Oncology, Department of Obstetrics and Gynecology [A.K.S., J.S.S., R.E.B.], and Department of Pharmacology [R.E.B.], University of Iowa Hospitals and Clinics, Iowa City, Iowa 52242
We hypothesize that genomic instability plays an important role in causing specific types of p53 mutations in ovarian cancer. To test this hypothesis, 78 tumors were analyzed for p53 mutations with SSCP analysis of the entire open reading frame. At the same time, alterations in 10 microsatellite loci including di-, tri-, and tetranucleotide repeats were evaluated. Fourteen (26%) of all mutations were insertion/deletion mutations. All insertion/deletion mutations were associated with one of the following features: runs of purines or pyrimidines, repeats of short sequences, or palindromes. There was a strong association of generalized microsatellite instability with p53 in contrast to tumors with other types of mutations or wild-type p53 (P = 0.007). These characteristic p53 mutations appear to be caused by generalized genomic instability rather than to be the direct cause of genomic instability. These findings suggest the existence of additional novel DNA repair genes important to the carcinogenic process.
1 A portion of this work was funded through an American Cancer Society institutional seed grant to R. E. B. (IRG-IN-122N). A. K. S. is a clinical fellow supported by American Cancer Society Clinical Oncology Fellowship Award 95-39-1 and the Ortho academic training fellowship from the American College of Obstetricians and Gynecologists.
2 To whom requests for reprints should be addressed, at Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, 4630 JCP, University of Iowa Hospitals and Clinics, Iowa City, IA 52242. Phone: (319) 356-2015; Fax: (319) 353-8363.
Received 10/30/96. Accepted 1/27/97.
This article has been cited by other articles:
|
|
 |
|
  V. S. Dhillon, M. Aslam, and S. A. Husain The Contribution of Genetic and Epigenetic Changes in Granulosa Cell Tumors of Ovarian Origin Clin. Cancer Res., August 15, 2004; 10(16): 5537 - 5545. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Reles, W. H. Wen, A. Schmider, C. Gee, I. B. Runnebaum, U. Kilian, L. A. Jones, A. El-Naggar, C. Minguillon, I. Schonborn, et al. Correlation of p53 Mutations with Resistance to Platinum-based Chemotherapy and Shortened Survival in Ovarian Cancer Clin. Cancer Res., October 1, 2001; 7(10): 2984 - 2997. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. M. Shin, N. Charuruks, S. M. Lippman, J. J. Lee, J. Y. Ro, W. K. Hong, and W. N. Hittelman p53 Protein Accumulation and Genomic Instability in Head and Neck Multistep Tumorigenesis Cancer Epidemiol. Biomarkers Prev., June 1, 2001; 10(6): 603 - 609. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. A. Ahrendt, P. A. Decker, K. Doffek, B. Wang, L. Xu, M. J. Demeure, J. Jen, and D. Sidransky Microsatellite Instability at Selected Tetranucleotide Repeats Is Associated with p53 Mutations in Non-Small Cell Lung Cancer Cancer Res., May 1, 2000; 60(9): 2488 - 2491. [Abstract] [Full Text]
|
|
|
|
|
|
A. K. Sood, J. I. Sorosky, M. Dolan, B. Anderson, and R. E. Buller Distant Metastases in Ovarian Cancer: Association with p53 Mutations Clin. Cancer Res., September 1, 1999; 5(9): 2485 - 2490. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. J. Rayanade, M. I. Ndubuisi, J. D. Etlinger, and P. B. Sehgal Regulation of IL-6 Signaling by p53: STAT3- and STAT5-Masking in p53-Val135-Containing Human Hepatoma Hep3B Cell Lines J. Immunol., July 1, 1998; 161(1): 325 - 334. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |
